Tectora Therapeutics develops oral medicines designed to treat immune-mediated diseases, specifically focusing on immunology and inflammation. The company co-develops its pipeline by utilizing advanced computational drug discovery platforms and preclinical capabilities. Its core value proposition centers on translating clinically validated biology into oral small-molecule therapies to address significant unmet patient needs.
tectoratx.comPart of: Series A: A Series